Carmell Co. (NASDAQ:CTCX – Get Free Report) saw a large growth in short interest in October. As of October 31st, there was short interest totalling 505,100 shares, a growth of 29.1% from the October 15th total of 391,200 shares. Currently, 3.8% of the company’s stock are sold short. Based on an average trading volume of 4,600,000 shares, the short-interest ratio is presently 0.1 days.
Hedge Funds Weigh In On Carmell
An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC purchased a new stake in Carmell Co. (NASDAQ:CTCX – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned 0.22% of Carmell at the end of the most recent quarter. 24.22% of the stock is owned by institutional investors and hedge funds.
Carmell Stock Down 17.7 %
NASDAQ:CTCX opened at $0.23 on Friday. The stock’s 50-day simple moving average is $0.38 and its 200 day simple moving average is $1.14. Carmell has a 52-week low of $0.20 and a 52-week high of $4.31.
Carmell Company Profile
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Stories
- Five stocks we like better than Carmell
- What Are Some of the Best Large-Cap Stocks to Buy?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Healthcare Dividend Stocks to Buy
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Pros And Cons Of Monthly Dividend Stocks
- Time to Load Up on Home Builders?
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.